Interestingly, in plasma DNA, the first detection of the TTI1 mutation was in a sample collected after adjuvant chemotherapy for treating primary tumor, and the second was after chemotherapy for treating lung metastasis, with VAFs of 2.6% and 4.2%, respectively. Here, TTI1 is linked to neoplasm.